Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
A Randomized Phase III Study of SOX vs. COX in Patients With Advanced Colorectal Cancer
Sponsor: Asan Medical Center
A PHASE3 clinical study on Colorectal Cancer, this trial is completed. The trial is conducted by Asan Medical Center and has accumulated 6 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jun 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asan Medical Center
- Chonnam National University Hospital
- Gachon University Gil Medical Center
- National Cancer Center, Korea
- Samsung Medical Center
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- Yonsei University
For direct contact, visit the study record on ClinicalTrials.gov .